ClinicalTrials.gg
RecruitingNCT05741411Updated May 22, 2026

Facilitating Access to Specialty Treatment

An interventional study of RPM-assisted specialist access in Mild Traumatic Brain Injury, Concussion, Mild and Concussion, Severe, sponsored by Children's Hospital of Philadelphia. Recruiting at 1 site in United States. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Children's Hospital of Philadelphia · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Not applicable
Ages
13 Years to 18 Years
Sex
All
01

Study summary

The goal of this hybrid implementation-effectiveness study is to evaluate the effectiveness (hastened recovery times) and feasibility (fidelity in connecting to concussion specialty care) of a novel mobile health intervention, designed to reduce disparities in access to specialty care through the use of remote patient monitoring (RPM) to facilitate care hand-off from the emergency department (ED) to concussion specialty care. Participants will report their symptoms and activity once daily through RPM chat technology that is linked to their electronic health record and prompts referral to specialty care.

02

Conditions studied

  • Mild Traumatic Brain Injury
  • Concussion, Mild
  • Concussion, Severe
  • Concussion, Intermediate

Keywords

  • mobile health
  • emergency department
  • persistent post-concussion symptoms
  • remote patient monitoring
03

In context

Brain Concussion

637 studies on the registry are indexed under Brain Concussion; 163 are open to participants now.

This study's planned enrollment of 210 is above the median of 63 across 446 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

Children's Hospital of Philadelphia is the lead sponsor of 489 studies on the registry; 90 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 22 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for concussed subjects:

  • Males and females age 13 - 18
  • Present to the Children's Hospital of Philadelphia (CHOP) Emergency Department (ED) within 72 hours of head injury
  • Meet criteria for concussion as defined by the most recent International Consensus Statement on Concussion
  • Own a smartphone
  • Meet criteria for moderate-to-high risk for Persistent Post-Concussion Symptoms according to 5P rule (score >3/12)

Exclusion Criteria for concussed subjects:

  • Glasgow Coma Scale score \<13
  • Lower extremity trauma
  • A prior concussion within 1 month
  • Non-English speaking
  • Admission to the hospital at the initial head injury visit
  • Previously enrolled in the study
  • Inability to complete study procedures.

Inclusion Criteria for parents:

  • Child meets the study eligibility criteria

Exclusion Criteria for parents:

  • Non-English speaking

Inclusion Criteria for providers:

  • ED or specialty provider caring for at least one patient via the mobile Health (mHealth)-facilitated care handoff strategy

Exclusion Criteria for providers:

  • Non-English speaking
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
210 participants (estimated)

Study arms

  • Experimental
    Concussed youth at risk for prolonged symptoms

    Other: RPM-assisted specialist access

Interventions

  • OtherRPM-assisted specialist access

    Participants will be prompted to report current symptoms and activity once a day via remote patient monitoring chat technology for up to 28 days following injury. Patients with either escalating or plateauing symptoms will be flagged, with an electronic alert sent via the electronic health record to a nurse navigator. The nurse navigator will have access to the symptom data and facilitate scheduling an in person or telehealth specialist visit as indicated. Symptoms will continue to be monitored through the 28-day acute study period with additional clinical visits occurring according to clinical need.

06

What researchers measure

Primary outcomes

  1. Incidence of Persisting Post-Concussion Symptoms (PPCS, Primary Effectiveness)

    Persistence of at least 3 concussion-like symptoms above the pre-injury state beyond 28 days from injury, defined as a positive difference between patient-reported symptoms and the perceived pre-injury symptom rating

    Time frame: 28 days from injury

  2. Percent of participants meeting referral criteria who interact with a specialty care provider (Fidelity, Primary Implementation)

    Among those participants who flag to see a specialist, at least 1 interaction with a specialty provider either in person or via telehealth during the acute study period

    Time frame: 28 days from injury

Secondary outcomes

  1. Modeling of PPCS (Secondary Effectiveness)

    Multivariate logistic regression evaluating the effect on the incidence of PPCS of socio-demographic and neighborhood-level economic variables, including race, ethnicity, sex, insurance, mechanism of injury, and child opportunity index, as well as known factors associated with PPCS, including age, concussion history, and co-morbid conditions

    Time frame: 28 days from injury

  2. Days until return to symptoms baseline (Secondary Effectiveness)

    Number of days from injury whereby patient-reported symptoms meets pre-injury baseline levels

    Time frame: Up to 90 days from injury

  3. Days until clearance (Secondary Effectiveness)

    Number of days from injury until patient is fully cleared for full activity by a medical provider

    Time frame: Up to 90 days from injury

  4. Days until return to school (Secondary Effectiveness)

    Number of days from injury until patient is able to return to full time school without accommodations

    Time frame: Up to 90 days from injury

  5. Modeling of fidelity (Secondary Implementation)

    Multivariate logistic regression evaluating the effect on fidelity of socio-demographic and neighborhood-level economic variables, including race, ethnicity, sex, insurance, mechanism of injury, and child opportunity index

    Time frame: 28 days from injury

  6. Patient-defined quantitative appropriateness (Secondary Implementation)

    Mean System Usability Score out of 100 with \>=70 defined as acceptable appropriateness

    Time frame: Within 1 year of completing study procedures

  7. Patient-defined qualitative appropriateness (Secondary Implementation)

    Themes from semi-structured interviews with patients related to intervention appropriateness will be identified

    Time frame: Within 1 year of completing study procedures

  8. Provider-defined qualitative acceptability (Secondary Implementation)

    Themes from semi-structured interviews with providers related to intervention acceptability will be identified

    Time frame: Within 1 year of completing study procedures

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Zemek R, Barrowman N, Freedman SB, Gravel J, Gagnon I, McGahern C, Aglipay M, Sangha G, Boutis K, Beer D, Craig W, Burns E, Farion KJ, Mikrogianakis A, Barlow K, Dubrovsky AS, Meeuwisse W, Gioia G, Meehan WP 3rd, Beauchamp MH, Kamil Y, Grool AM, Hoshizaki B, Anderson P, Brooks BL, Yeates KO, Vassilyadi M, Klassen T, Keightley M, Richer L, DeMatteo C, Osmond MH; Pediatric Emergency Research Canada (PERC) Concussion Team. Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED. JAMA. 2016 Mar 8;315(10):1014-25. doi: 10.1001/jama.2016.1203. PubMed 26954410 ↗
  • Corwin DJ, Arbogast KB, Haber RA, Pettijohn KW, Zonfrillo MR, Grady MF, Master CL. Characteristics and Outcomes for Delayed Diagnosis of Concussion in Pediatric Patients Presenting to the Emergency Department. J Emerg Med. 2020 Dec;59(6):795-804. doi: 10.1016/j.jemermed.2020.09.017. Epub 2020 Oct 7. PubMed 33036827 ↗
  • Master CL, Master SR, Wiebe DJ, Storey EP, Lockyer JE, Podolak OE, Grady MF. Vision and Vestibular System Dysfunction Predicts Prolonged Concussion Recovery in Children. Clin J Sport Med. 2018 Mar;28(2):139-145. doi: 10.1097/JSM.0000000000000507. PubMed 29064869 ↗
  • Desai N, Wiebe DJ, Corwin DJ, Lockyer JE, Grady MF, Master CL. Factors Affecting Recovery Trajectories in Pediatric Female Concussion. Clin J Sport Med. 2019 Sep;29(5):361-367. doi: 10.1097/JSM.0000000000000646. PubMed 31460948 ↗
  • Wiebe DJ, Nance ML, Houseknecht E, Grady MF, Otto N, Sandsmark DK, Master CL. Ecologic Momentary Assessment to Accomplish Real-Time Capture of Symptom Progression and the Physical and Cognitive Activities of Patients Daily Following Concussion. JAMA Pediatr. 2016 Nov 1;170(11):1108-1110. doi: 10.1001/jamapediatrics.2016.1979. No abstract available. PubMed 27617669 ↗
  • Corwin DJ, Orchinik J, D'Alonzo B, Agarwal AK, Pettijohn KW, Master CL, Wiebe DJ. A Randomized Trial of Incentivization to Maximize Retention for Real-Time Symptom and Activity Monitoring Using Ecological Momentary Assessment in Pediatric Concussion. Pediatr Emerg Care. 2023 Jul 1;39(7):488-494. doi: 10.1097/PEC.0000000000002870. Epub 2022 Nov 3. PubMed 36730797 ↗
  • Corwin DJ, Godfrey M, Arbogast KB, Zorc JJ, Wiebe DJ, Michel JJ, Barnett I, Stenger KM, Calandra LM, Cobb J, Winston FK, Master CL. Using mobile health to expedite access to specialty care for youth presenting to the emergency department with concussion at highest risk of developing persisting symptoms: a protocol paper for a non-randomised hybrid implementation-effectiveness trial. BMJ Open. 2024 Jun 19;14(6):e082644. doi: 10.1136/bmjopen-2023-082644. PubMed 38904136 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05741411
Responsible party
Sponsor
First posted
Feb 23, 2023
Start date
Mar 11, 2024
Primary completion
Mar 31, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
May 22, 2026

Study contacts

Melissa Godfrey
Contact
godfreym2@chop.edu
267-425-0386
Daniel J Corwin, MD, MSCE
principal investigator · Children's Hospital of Philadelphia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion